- Home
- FPF vs CLDX Comparison
FPF vs CLDX Comparison
Compare FPF & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPF
- CLDX
- Stock Information
- Founded
- FPF 2013
- CLDX N/A
- Country
- FPF United States
- CLDX United States
- Employees
- FPF N/A
- CLDX N/A
- Industry
- FPF Trusts Except Educational Religious and Charitable
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FPF Finance
- CLDX Health Care
- Exchange
- FPF Nasdaq
- CLDX Nasdaq
- Market Cap
- FPF 999.7M
- CLDX 1.2B
- IPO Year
- FPF N/A
- CLDX 2008
- Fundamental
- Price
- FPF $17.11
- CLDX $18.30
- Analyst Decision
- FPF
- CLDX Buy
- Analyst Count
- FPF 0
- CLDX 8
- Target Price
- FPF N/A
- CLDX $54.29
- AVG Volume (30 Days)
- FPF 186.7K
- CLDX 935.8K
- Earning Date
- FPF 01-01-0001
- CLDX 05-05-2025
- Dividend Yield
- FPF 8.08%
- CLDX N/A
- EPS Growth
- FPF N/A
- CLDX N/A
- EPS
- FPF N/A
- CLDX N/A
- Revenue
- FPF N/A
- CLDX $7,020,000.00
- Revenue This Year
- FPF N/A
- CLDX N/A
- Revenue Next Year
- FPF N/A
- CLDX N/A
- P/E Ratio
- FPF N/A
- CLDX N/A
- Revenue Growth
- FPF N/A
- CLDX 1.99
- 52 Week Low
- FPF $13.91
- CLDX $14.40
- 52 Week High
- FPF $18.09
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- FPF 40.31
- CLDX 49.59
- Support Level
- FPF $16.82
- CLDX $17.45
- Resistance Level
- FPF $17.28
- CLDX $18.53
- Average True Range (ATR)
- FPF 0.43
- CLDX 1.37
- MACD
- FPF -0.03
- CLDX 0.29
- Stochastic Oscillator
- FPF 52.61
- CLDX 71.69
About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.